847952-36-7

Basic information

• Product Name: Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)- (9CI)
• Synonyms: Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)- (9CI);(8aS)-hexahydro-8a-Methyl-Pyrrolo[1,2-a]pyrazine-1,4-dione;(8AS)-8A-METHYL-OCTAHYDROPYRROLO[1,2-A]PIPERAZINE-1,4-DIONE
• CAS NO: 847952-36-7
• Molecular Formula: C8H12N2O2
• Molecular Weight: 168.19308
• Product Categories: PYRROLE
• Mol File: 847952-36-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)- (9CI)(847952-36-7)
• EPA Substance Registry System: Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)- (9CI)(847952-36-7)

Safety Data

• Hazardous Substances Data: 847952-36-7(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)(9CI) is used as a building block in organic synthesis for the creation of more complex molecules and compounds. Its heterocyclic nature and specific stereochemistry make it a valuable component in the development of novel chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-8a-methyl-, (8aS)(9CI) is used as a potential candidate for drug discovery and development. Its unique structure may contribute to the design of new therapeutic agents, particularly in the areas of medicinal chemistry and drug design, where innovative molecular scaffolds are constantly sought after.

Upstream product

• 847952-40-3 (S)-methyl 1-(2-(((benzyloxy)carbonyl)amino)acetyl)-2-methylpyrrolidine-2-carboxylate 
• 42856-71-3 (S)-2-methylpyrrolidine-2-carboxylic acid 
• 220060-08-2 methyl (S)-2-methylpyrrolidine-2-carboxylate monohydrochloride 
• 220200-88-4 (3R,7aS)-7a-methyl-3-(trichloromethyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one 
• 118916-60-2 (2R,5S)-2-trichloromethyl-1-aza-3-oxabicyclo[3.3.0]octan-4-one 

Relevant articles and documents

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

Embodiments of this invention provide compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat Pitt Hopkins Syndrome and symptoms thereof, as well a

1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

NEUROPROTECTIVE BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING AUTISM SPECTRUM DISORDERS AND NEURODEVELOPMENTAL DISORDERS

Embodiments of this invention provide compositions and methods for therapeutic use of diketopiperazines including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat symptoms of Autism Spectrum Disorders and Neurodevelopmental Diso

Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists

Bicyclic piperazine derivatives were synthesized as conformationally constrained analogs of N-alkyl piperazines and were found to be potent CB1 receptor agonists. The CB1 receptor agonist activity was dependent upon the absolute configuration of the chiral center of the bicyclic ring system. Although the conformational constraint did not protect the compounds from metabolism by N-dealkylation, several bicyclic analogs were found to be more potent than the unconstrained lead compound. Compound 8b demonstrated potent antinociceptive activity in vivo.

CYCLIC GLYCYL-2-ALLYL PROLINE IMPROVES COGNITIVE PERFORMANCE IN IMPAIRED ANIMALS

Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such condit

NEUROPROTECTIVE BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE

Embodiments of this invention provide novel cyclic compounds structurally related to diketopiperazines and methods for their therapeutic use. Such compounds are neuroprotective and have utility as therapeutic agents for treatment of diseases, injuries and